Price disclosure 2018 April cycle outcomes summary

12 January 2018 - The summary of price disclosure price reductions for the 2018 April Cycle (fourth remove originator cycle) has ...

Read more →

Explainer: how is the price of medicine decided in Australia?

20 November 2017 - The cost governments are willing to pay drug companies for medicines depends on the outcome the drug ...

Read more →

Prescription medicine for cancer, cholesterol and contraception is about to get cheaper

30 September 2017 - The price of more than 1400 medicines including the nation’s biggest selling drug the anti-cholesterol pill ...

Read more →

Confirmed 1 October 2017 prices - 2017 October cycle

14 September 2017 - Confirmed 1 October 2017 prices resulting from the 2017 October cycle of price disclosure have now been ...

Read more →

Government moves to legislate to increase generic and biosimilar medicine uptake and cut medicine prices

24 July 2017 - Australia has long lagged behind the USA and UK in its use of generic pharmaceuticals – ...

Read more →

Indicative 1 October 2017 prices - 2017 October cycle

13 July 2017 - Indicative 1 October 2017 prices resulting from the 2017 October cycle of price disclosure have now been ...

Read more →

Government pharmacy shake-up set to hit Australians’ hip pockets

 3 July 2017 - A federal government plan could see some medicine prices soar by more than $8 per prescription ...

Read more →

Price disclosure 2017 October cycle outcomes summary

16 June 2017 - The summary of price disclosure price reductions for the 2017 October Cycle (Third Remove Originator cycle) has ...

Read more →

Why you could have to pay $1 more for medicine

13 May 2017 - Health Minister Greg Hunt has changed his script - and the change is about to hit ...

Read more →

Budget 2017: PBS shake-up to cut cost of drugs

9 May 2017 - Price reforms in the Pharmaceutical Benefits Scheme will deliver $1.8 billion in savings over five years, ...

Read more →

Strategic Agreement between the Innovative pharmaceutical industry and government delivers certainty for industry, savings to taxpayers and benefits to patients

9 May 2017 - Medicines Australia has signed a strategic agreement with the Australian Government that will support ongoing access ...

Read more →

Drugs and manners of administration that meet the F2/multi-brand criteria (30 month clock for originator removal calculation) for the 2017 October Cycle

7 April 2017 - A list of drugs and manners of administration that meet the F2/multi-brand criteria (30 month clock for ...

Read more →

Payers’ experiences with confidential pharmaceutical price discounts: a survey of public and statutory health systems in North America, Europe, and Australasia

1 April 2017 - Institutional payers for pharmaceuticals worldwide appear to be increasingly negotiating confidential discounts off of the official list ...

Read more →

The hidden cost keeping your health insurance premiums high

30 March 2017 - Private health insurance costs for everyone could drop dramatically if the Federal Government tackled murky practices relating ...

Read more →

Federal Government announce 1100 medicines to have prices cut including rosuvastatin

25 March 2017 - Sick Australians will save $500 million over four years and up to $200 a year each ...

Read more →